What is Algernon Pharmaceuticals Inc.'s stock symbol?

The Company is currently listed on the Canadian Securities Exchange with the symbol AGN.CN, the OTCQB with the symbol AGNPF and the Frankfurt Stock Exchange with the symbol AGW.

When was Algernon Pharmaceuticals Inc. incorporated?

April 10, 2015

When did Algernon Pharmaceuticals Inc. become a public company?

February 1, 2016

Where is Algernon Pharmaceuticals Inc. located?

601 West Broadway
Suite 400
Vancouver, BC V5Z 4C2

When is Algernon Pharmaceuticals Inc.'s fiscal year end?

August 31st

What is Algernon NeuroScience?

Algernon NeuroScience is a wholly owned private equity subsidiary of Algernon Pharmaceuticals and has been created to advance the Company’s DMT stroke and traumatic brain injury (TBI) research program.

When was Algernon NeuroScience established?

Algernon NeuroScience was incorporated on December 9, 2022.

Who is Algernon Pharmaceuticals Inc.'s transfer agent?

TSX Trust Company
1066 W. Hastings Street
Suite 1600
Vancouver, BC V6E 3X1
T: 604-235-3700

Who is Algernon Pharmaceuticals Inc.'s independent auditor?

Smythe LLP
Suki Gill
475 Howe Street
Suite 1700
Vancouver, BC V6C 2B3
T: 604-687-1231

Who is Algernon Pharmaceuticals Inc.'s outside legal counsel?

McMillan LLP
Desmond Balakrishnan
1055 West Georgia Street
Suite 1500
Vancouver, BC V6E 4N7
T: 604-689-9111